Annual Results Results Snapshot
Figures in Cr
Standalone - Balance Sheet Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2026 is 5.95% vs 9.71% in Mar 2025
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2026 is -2.48% vs -2.11% in Mar 2025
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2026 is -6.24% vs -41.17% in Mar 2025
Compare Balance Sheet Results of Krebs Biochem
Figures in Cr
Standalone - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
21.56
12.59
8.97
71.25%
Share Warrants & Outstandings
Total Reserve
-184.32
45.68
-230.00
-503.50%
Shareholder's Funds
-162.75
64.79
-227.54
-351.20%
Minority Interest
0.00
0.00
0.00
0.00%
Long-Term Borrowings
163.55
22.86
140.69
615.44%
Secured Loans
0.00
22.86
-22.86
-100.00%
Unsecured Loans
163.55
0.00
163.55
0.00%
Deferred Tax Assets / Liabilities
0.00
3.59
-3.59
-100.00%
Other Long Term Liabilities
45.00
0.76
44.24
5,821.05%
Long Term Trade Payables
1.61
0.00
1.61
0.00%
Long Term Provisions
2.78
1.44
1.34
93.06%
Total Non-Current Liabilities
212.94
28.64
184.30
643.51%
Current Liabilities
Trade Payables
13.76
37.68
-23.92
-63.48%
Other Current Liabilities
37.32
12.38
24.94
201.45%
Short Term Borrowings
61.29
38.80
22.49
57.96%
Short Term Provisions
0.70
0.95
-0.25
-26.32%
Total Current Liabilities
113.07
89.80
23.27
25.91%
Total Liabilities
163.25
183.23
-19.98
-10.90%
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00%
Gross Block
314.01
108.10
205.91
190.48%
Less: Accumulated Depreciation
172.30
39.79
132.51
333.02%
Less : Impairment of Assets
0.00
0.00
0.00
0.00%
Net Block
141.71
68.31
73.40
107.45%
Lease Adjustment
0.00
0.00
0.00
0.00%
Capital Work in Progress
1.59
0.27
1.32
488.89%
Intangible assets under development
0.00
0.00
0.00
0.00%
Pre-operative Expenses pending
0.00
0.00
0.00
0.00%
Assets in transit
0.00
0.00
0.00
0.00%
Non Current Investments
0.00
0.00
0.00
0.00%
Long Term Loans & Advances
10.33
11.90
-1.57
-13.19%
Other Non Current Assets
0.00
3.33
-3.33
-100.00%
Total Non-Current Assets
153.62
84.61
69.01
81.56%
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00%
Inventories
5.70
55.95
-50.25
-89.81%
Sundry Debtors
0.00
33.46
-33.46
-100.00%
Cash and Bank
0.13
0.74
-0.61
-82.43%
Other Current Assets
0.35
1.43
-1.08
-75.52%
Short Term Loans and Advances
3.43
7.05
-3.62
-51.35%
Total Current Assets
9.62
98.62
-89.00
-90.25%
Net Current Assets (Including Current Investments)
-103.44
8.82
-112.26
-1,272.79%
Total Current Assets Excluding Current Investments
9.62
98.62
-89.00
-90.25%
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00%
Total Assets
163.25
183.23
-19.98
-10.90%
Contingent Liabilities
10.26
12.92
-2.66
-20.59%
Total Debt
224.84
61.66
163.18
264.64%
Book Value per share (adjusted)
-75.49
46.28
-121.77
-263.12%
Annual - Borrowings
Borrowings 224.84 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is 5.95% vs 9.71% in Mar 2025
Annual - Other Long Term Liabilities
Other Long Term Liabilities 45.00 Cr
in Mar 2026Figures in Cr
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 143.30 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -2.48% vs -2.11% in Mar 2025
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 9.62 Cr
in Mar 2026Figures in Cr
YoY Growth in year ended Mar 2026 is -6.24% vs -41.17% in Mar 2025
